Media
What Others Are Saying About the 2024 ISPE Annual Meeting & Expo
Luxturna Maker Spark Therapeutics’ Flexible Platform Approach
Chris Stevens, Chief Patient Supply Officer at Spark Therapeutics, will be a keynote speaker for the 2024 ISPE Annual Meeting & Expo. Stevens discusses the platform concept and how their Gene Therapy Innovation Center in Philadelphia, Pennsylvania, USA may have cracked the code to flexibility. He also touches on digital twins, facility design applications, scaling, and lessons learned – all of which will be covered in depth during his planned presentation at the upcoming conference.
A Year In, Sanofi’s Journey with Plai AI Is Aiding Quality Decisions
Miguelina Matthews, PhD, Head of External Liaison at Sanofi, has been selected as a speaker for the 2024 ISPE Annual Meeting & Expo. In this article which previews her planned discussion, Matthews shares how Sanofi has “gone all in on AI.” Furthermore, she discusses Sanofi’s “plai” use case, which entails leveraging AI to synthesize company-wide data so that teams can make better decisions.
This Takeda Official Thinks Pharma 4.0™ Won't Be Optional Much Longer
Gunter Baumgartner, SVP Head of Global Engineering at Takeda Pharmaceuticals International AG, will be a keynote speaker for the 2024 ISPE Annual Meeting & Expo. Baumgartner, who is also a 2024 ISPE Facility of the Year Awards (FOYA) Judge, discusses Pharma 4.0™, interoperability, digital technology advancements, augmented and virtual reality, AI and machine learning, their inevitable integration into all aspects of the pharmaceutical industry, and more in this article ahead of his planned keynote presentation at the 2024 ISPE Annual Meeting & Expo.
Takeda Cut Its PPQ Timeline With beePFS — Here's How
Takeda has been recognized as a 2024 ISPE Facility of the Year Awards (FOYA) category winner in the Operations – Facility Fit. In this Q&A interview, Outsourced Pharma discusses Takeda’s successful beePFS project with Roland Fabris, Managing Director and Site Head of Takeda in Linz, Austria. In the article, he details how Takeda was able to complete all process performance qualification (PPQ) runs 50 percent faster than standard projects with a similar scope.
How Eli Lilly's Making Peptides Faster and More Reliably
Eli Lilly has been recognized as a 2024 ISPE Facility of the Year Awards (FOYA) – Innovation category winner. In this Q&A interview, Pharmaceutical Online discusses Eli Lilly and Company’s approach to high-throughput peptide manufacturing with Matt Foster, Darragh McDonagh, and Kevin Seibert, of Eli Lilly and Company.
Chugai's Race to Zero Emissions at UK4 In Tokyo
Chugai Pharma Manufacturing Co., Ltd. has been recognized as a 2024 ISPE Facilities of the Year Award (FOYA) – Social Impact category winner. In this Q&A interview, Bioprocess Online discusses Chugai’s innovative approach to achieving zero emissions at its new UK4 site in Tokyo, Japan, with Shingo Goto, a construction project manager at UK4.